Inhibition of PrP^Sc formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives

References

• Prusiner SB. Shattuck lecture--neurodegenerative diseases and prions. N Engl J Med 2001; 344:1516 - 26; http://dx.doi.org/10.1056/NEJM200105173442006; PMID: 11357156
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Glatzel M, Montrasio F, Prinz M, Heppner FL. Interventional strategies against prion diseases. Nat Rev Neurosci 2001; 2:745 - 9; http://dx.doi.org/10.1038/35094590; PMID: 11584312
   PubMed Web of Science ®Google Scholar
• Cashman NR, Caughey B. Prion diseases--close to effective therapy?. Nat Rev Drug Discov 2004; 3:874 - 84; http://dx.doi.org/10.1038/nrd1525; PMID: 15459678
   PubMed Web of Science ®Google Scholar
• Solassol J, Crozet C, Lehmann S. Prion propagation in cultured cells. Br Med Bull 2003; 66:87 - 97; http://dx.doi.org/10.1093/bmb/66.1.87; PMID: 14522851
   PubMed Web of Science ®Google Scholar
• Béranger F, Mangé A, Solassol J, Lehmann S. Cell culture models of transmissible spongiform encephalopathies. Biochem Biophys Res Commun 2001; 289:311 - 6; http://dx.doi.org/10.1006/bbrc.2001.5941; PMID: 11716473
   PubMed Web of Science ®Google Scholar
• Trevitt CR, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006; 129:2241 - 65; http://dx.doi.org/10.1093/brain/awl150; PMID: 16816391
   PubMed Web of Science ®Google Scholar
• Gilch S, Nunziante M, Ertmer A, Schätzl HM. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation. Vet Microbiol 2007; 123:377 - 86; http://dx.doi.org/10.1016/j.vetmic.2007.04.006; PMID: 17493775
   PubMed Web of Science ®Google Scholar
• Caughey B, Raymond GJ. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 1993; 67:643 - 50; PMID: 7678300
   PubMed Web of Science ®Google Scholar
• Yudovin-Farber I, Azzam T, Metzer E, Taraboulos A, Domb AJ. Cationic polysaccharides as antiprion agents. J Med Chem 2005; 48:1414 - 20; http://dx.doi.org/10.1021/jm049378o; PMID: 15743185
   PubMed Web of Science ®Google Scholar
• Mangé A, Nishida N, Milhavet O, McMahon HE, Casanova D, Lehmann S. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol 2000; 74:3135 - 40; http://dx.doi.org/10.1128/JVI.74.7.3135-3140.2000; PMID: 10708429
   PubMed Web of Science ®Google Scholar
• Pocchiari M, Schmittinger S, Masullo C. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J Gen Virol 1987; 68:219 - 23; http://dx.doi.org/10.1099/0022-1317-68-1-219; PMID: 2433387
   PubMed Web of Science ®Google Scholar
• Rudyk H, Vasiljevic S, Hennion RM, Birkett CR, Hope J, Gilbert IH. Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. J Gen Virol 2000; 81:1155 - 64; PMID: 10725446
   PubMed Web of Science ®Google Scholar
• Supattapone S, Nishina K, Rees JR. Pharmacological approaches to prion research. Biochem Pharmacol 2002; 63:1383 - 8; http://dx.doi.org/10.1016/S0006-2952(02)00874-2; PMID: 11996878
   PubMed Web of Science ®Google Scholar
• Korth C, May BC, Cohen FE, Prusiner SB. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A 2001; 98:9836 - 41; http://dx.doi.org/10.1073/pnas.161274798; PMID: 11504948
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 2003; 77:10288 - 94; http://dx.doi.org/10.1128/JVI.77.19.10288-10294.2003; PMID: 12970413
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Morrey JD, Race RE, Chen J, Caughey B. Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. J Gen Virol 2004; 85:2479 - 83; http://dx.doi.org/10.1099/vir.0.80082-0; PMID: 15269390
   PubMed Web of Science ®Google Scholar
• Thompson MJ, Borsenberger V, Louth JC, Judd KE, Chen B. Design, synthesis, and structure-activity relationship of indole-3-glyoxylamide libraries possessing highly potent activity in a cell line model of prion disease. J Med Chem 2009; 52:7503 - 11; http://dx.doi.org/10.1021/jm900920x; PMID: 19842664
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Kawagoe K, Chen CJ, Teruya K, Sakasegawa Y, Doh-ura K. Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner. J Virol 2007; 81:12889 - 98; http://dx.doi.org/10.1128/JVI.01563-07; PMID: 17881452
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, May BC, Renslo AR, Prusiner SB. Discovery of 2-aminothiazoles as potent antiprion compounds. J Virol 2010; 84:3408 - 12; http://dx.doi.org/10.1128/JVI.02145-09; PMID: 20032192
   PubMed Web of Science ®Google Scholar
• Wang L, Ankati H, Akubathini SK, Balderamos M, Storey CA, Patel AV, et al. Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration. J Neurosci Res 2010; 88:1970 - 84; PMID: 20143421
   PubMed Web of Science ®Google Scholar
• Koini EN, Papazafiri P, Vassilopoulos A, Koufaki M, Horváth Z, Koncz I, et al. 5,7,8-Trimethyl-benzopyran and 5,7,8-trimethyl-1,4-benzoxazine aminoamide derivatives as novel antiarrhythmics against ischemia-reperfusion injury. J Med Chem 2009; 52:2328 - 40; http://dx.doi.org/10.1021/jm801228h; PMID: 19309156
   PubMed Web of Science ®Google Scholar
• Race RE, Fadness LH, Chesebro B. Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol 1987; 68:1391 - 9; http://dx.doi.org/10.1099/0022-1317-68-5-1391; PMID: 3106566
   PubMed Web of Science ®Google Scholar
• Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, Grassi J, et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 2000; 74:320 - 5; http://dx.doi.org/10.1128/JVI.74.1.320-325.2000; PMID: 10590120
   PubMed Web of Science ®Google Scholar
• Vilette D. Cell models of prion infection. Vet Res 2008; 39:10; http://dx.doi.org/10.1051/vetres:2007049; PMID: 18073097
   PubMed Web of Science ®Google Scholar
• Gao H, Frost MR, Siegwart JT Jr., Norton TT. Patterns of mRNA and protein expression during minus-lens compensation and recovery in tree shrew sclera. Mol Vis 2011; 17:903 - 19; PMID: 21541268
   PubMed Web of Science ®Google Scholar
• Maier T, Güell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett 2009; 583:3966 - 73; http://dx.doi.org/10.1016/j.febslet.2009.10.036; PMID: 19850042
   PubMed Web of Science ®Google Scholar
• Schedel J, Distler O, Woenckhaus M, Gay RE, Simmen B, Michel BA, et al. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis. Ann Rheum Dis 2004; 63:1205 - 11; http://dx.doi.org/10.1136/ard.2003.006312; PMID: 15361372
   PubMed Web of Science ®Google Scholar
• MacKay VL, Li X, Flory MR, Turcott E, Law GL, Serikawa KA, et al. Gene expression analyzed by high-resolution state array analysis and quantitative proteomics: response of yeast to mating pheromone. Mol Cell Proteomics 2004; 3:478 - 89; http://dx.doi.org/10.1074/mcp.M300129-MCP200; PMID: 14766929
   PubMed Web of Science ®Google Scholar
• Koini EN, Avlonitis N, Calogeropoulou T. Simple and Efficient Method for the Halogenation of Oxygenated Aromatic Compounds. Synlett 2011; 1537 - 42
   Web of Science ®Google Scholar
• Filippou PS, Koini EN, Calogeropoulou T, Kalliakmani P, Panagiotidis CA, Kyriakidis DA. Regulation of the Escherichia coli AtoSC two component system by synthetic biologically active 5;7;8-trimethyl-1;4-benzoxazine analogues. Bioorg Med Chem 2011; 19:5061 - 70; http://dx.doi.org/10.1016/j.bmc.2011.06.029; PMID: 21757361
   PubMed Web of Science ®Google Scholar